This review addresses the main structural types of matrix metalloproteinase (MMP) inhibitors - hydroxamic acid derivatives, sulfonamides, bisphosphonates, compounds combining phosphoryl and hydroxamate groups, and functional derivatives of phosphonic and phosphinic acids. The selectivity of the inhibitory actions of these substances in relation to different types of MMP and the potential for the practical application of these substances in cancer treatment are discussed.
Similar content being viewed by others
References
K. D. Johnstone, T. Karoli, K. Dredge, et al., J. Med. Chem., 53(4), 1686 – 1699 (2010).
E. I. Deryugina and J. P. Quigley, Matrix Biol., 44 – 46, 94 – 112 (2015).
M. Mori, A. Massaro, V. Calderone, et al., ACS Med. Chem. Let., 4(6), 565 – 569 (2013).
E. Ishimwe, J. J. Hodgson, and A. L. Passarelli, Virology, 48, 166 – 178 (2015).
A. Yabluchanskiy, Y. Ma, R. P. Iyer, et al., Physiology, 28(6), 391 – 403 (2013).
F. Ke, Y. Wang, J. Hong, et al., Fish Shellfish Immunol., 45(2), 260 – 267 (2015).
W. J. Akers, B. Xu, H. Lee, et al., Bioconjugate Chem., 23(3), 656 – 663 (2012).
J. Lauer-Fields, K. Brew, J. K. Whitehead, et al., J. Am. Chem. Soc., 129(34), 10,408 – 10,417 (2007).
E. Ishimwe, J. J. Hodgson, R. J. Clem, et al., Virology, 479 – 480, 637 – 649 (2015).
G. N. Marchenko, N. D. Marchenko, and A. Y. Strongin, Biochem. J., 372(2), 503 – 515 (2003).
M. M. Pacheco, M. Mourao, E. B. Mantovani, et al., Clin. Exp. Metastasis, 16(7), 577 – 585 (1998).
E. A. Baker, F. G. Bergin, and D. J. Leaper, Br. J. Surg., 87(9), 1215 – 1221 (2000).
H. Kuniyasu, P. Troncoso, D. Johnston, et al., Clin. Cancer Res., 6(6), 2295 – 2308 (2000).
H. Nomura, N. Fujimoto, M. Seiki, et al., Int. J. Cancer., 69(1), 9 – 16 (1996).
U. B. Hofmann, and J. R. Westphal, A. J. Zendman, et al., J. Pathol, 191(3), 245 – 256 (2000).
N. Eiró, B. Fernandez-Garcia, L. O. González, et al., Oncoimmunology, 2(5), e24010 (2013).
K. Brew and M. Lizotte-Waniewski, Encyclopedia Cell Biol., 1, 706 – 713 (2015).
K. Brew and H. Nagase, BBA Molecular Cell Res., 1803, No. 1, 55 – 71 (2010).
J. A. Jacobsen, J. L. Major Jourden, M. T. Miller, et al., BBA Molecular Cell Res., 1801(1), 72 – 94 (2010).
J. Cathcart and A. Pulkoski-Gross, J. Cao, Genes Diseas., 2(1), 26 – 34 (2015).
J. F. Fisher and S. Mobashery, Cancer Metastasis Rev., 25(1), 115 – 136 (2006).
H. Hirte, I. B. Vergote, J. R. Jeffrey, et al., Gynecol. Oncol., 102(2), 300 – 308 (2006).
R. E. Vandenbroucke and C. Libert, Nature Reviews Drug Discovery, 13(12), 904 – 927 (2014).
M. Coussens, B. Fingleton, and L. M. Matrisian, Science, 295, 2387 – 2392 (2002).
A. Dufour and C. M. Overall, Trends Pharmacol. Sci., 34(4), 233 – 242 (2013).
M. Pérez-Sayáns García, J. M. Suárez-Peñaranda, P. Gayoso-Diz, et al., Cancer Let., 323(1), 11 – 19 (2012).
A. Veerendhar, R. Reich, and E. Breuer, Comptes Rendus Chimie, 13(8 – 9), 1191 – 1202 (2010).
P. Jain, C. Saravanan, and S. K. Singh, Eur. J. Med. Chem., 60, 89 – 100 (2013).
X.-C. Cheng, Q. Wang, H. Fang, et al., Bioorgan. Medicinal Chem., 16, 7932 – 7938 (2008).
X.-Q. Yan, and Z.-C. Wang, Z. Li, et al., Bioorgan. Med. Chem. Let., 25(20), 4664 – 4671 (2015).
F. Grams, H. Brandstetter, S. D’Alo, et al., Biol. Chem., 382(8), 1277 – 1285 (2001).
H.-J. Breyholz, M. Schäfers, S. Wagner, et al., J. Med. Chem., 48(9), 3400 – 3409 (2005).
D. Schrigten, H.-J. Breyholz, S. Wagner, et al., J. Med. Chem., 55(1), 223 – 232 (2012).
J. Wang, S. O’Sullivan, S. Harmon, et al., J. Med. Chem., 55(5), 2154 – 2162 (2012).
O. Teronen, Y. T. Konttinen, C. Lindqvist, et al., J. Dent. Res., 76(9), 1529 – 1537 (1997).
M. Sawa, T. Kiyoi, K. Kurokawa, et al., J. Med. Chem., 45(4), 919 (2002).
A. Hoffman, B. Qadri, J. Frant, et al., J. Med. Chem., 51(5), 1406 – 1414 (2008).
R. Reich, A. Hoffman, A. Veerendhar, et al., J. Med. Chem., 55(17), 7875 – 7882 (2012).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 51, No. 3, pp. 13 – 19, March, 2017.
Rights and permissions
About this article
Cite this article
Kapranov, L.E., Reznikov, A.N. & Klimochkin, Y.N. The Main Structural Types of Inhibitors of Matrix Metalloproteinases. Pharm Chem J 51, 175–181 (2017). https://doi.org/10.1007/s11094-017-1577-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-017-1577-4